Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes
β Scribed by Yang, X.; Wang, Y.; Luk, A. O. Y.; So, W. Y.; Ma, R. C. W.; Kong, A. P. S.; Xu, G.; Chan, J. C. N.
- Book ID
- 120324226
- Publisher
- Bioscientifica
- Year
- 2012
- Tongue
- English
- Weight
- 203 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1351-0088
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC
## Abstract Thirtyβfour patients from the Philadelphia area with hepatocellular carcinoma (HCC) were matched with colon cancer patients, lung cancer patients and blood donors according to age and sex. Sera from the four groups were tested to determine the prevalence of hepatitis B surface antigen (
## Abstract Antibody to hepatitis B surface antigen (HBsAg) (antiβHBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and antiβHBs (concurrent HBsAg/ antiβHBs) with hepatocellular carcinoma (HCC). The aim of t